SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 7-[2-(2-AMINOOXAZOL-4-YL)-(Z)
In a previous paper3), we reported on the synthesis and the biological activity of 3-methoxymethyl cephalosporin derivatives, one of which, cefpodoxime proxetil (Fig. 1) , has been successfully developed as a prodrug for oral use. Our further elaboration for developing orally active cephalosporins has been made in the direction of chemical modification of the C-7 acyl substituent of the 3-methoxymethyl cephalosporin derivatives.
acetamido] -3-methoxymethyl cephalosporin derivatives (4 and 5) were prepared in a similar manner to that described in previous papers3'40 as illustrated in the following scheme.
The antibacterial activity of the 7-aminooxazolyl derivatives (4a~4e) is shown in Table 1 . These compounds showed fairly good potency against the tested organisms especially against Gram-positive strains.
Among them, methoxime (4a) and 2- Table 1 . Antibacterial activity (MIC, /*g/ml)a of 7-aminooxazolyl derivatives (4a~4e). Agar dilution method: Nutrient agar; 107 cfu/ml.
Cefpodoxime.
j9-Lactamase producing strains.
fluoroethoxime (4d) derivatives exhibited excellent activity, however, the potency against Gramnegative organisms was slightly inferior to that of cefpodoxime. The subsequent introduction of an electron-withdrawing (4c) or a lipophilic (4b and 4e) moiety in place of the methyl group on the oxime substituent did not lead to a significant improvement in activity.
Although the acid derivatives (4) exhibited potent antibacterial activity, they showed poor urinary recovery after oral administration to mice. Consequently, the acids were converted to orally active pivaloyloxymethyl (POM) esters2' 5' 6* (5). The POM ester derivatives 5a (R2=CH3) and 5d (R2= CH2CH2F) showed remarkably improved urinary recoveries of 67% and 45%, respectively.
